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TO THE EDITOR
Laminin-332 is a large extracellular
basement membrane zone protein that
is critical for dermal–epidermal cohe-
sion. The laminin-332 heterotrimer (a3/
b3/g2) is believed to link keratinocytes
with the basement membrane zone by
simultaneously binding epidermal in-
tegrin receptors via the C-terminal
globular domain of its a3 chain, and
type VII collagen through domains on
the short arm of its b3 chain (Chen
et al., 1997; Rousselle et al., 1997).
Antibody-induced inhibition of lami-
nin-332’s integrin-binding domains
produces extensive skin blistering
(Rousselle et al., 1991; Kirtschig et al.,
1995); however, the in vivo signi-
ficance of the laminin b3 short arm in
dermal–epidermal cohesion has not
been tested directly.
To further study the laminin b3 short
arm in dermal–epidermal cohesion, we
produced two deletion mutants of the
laminin b3 cDNA. One (DVI) contained
a deletion of domain VI (LN) but left the
type VII collagen-binding domain intact.
The other contained a deletion of the
entire b3 short arm I comprising
domains VI and V-III (LN, LE, LF), which
includes the collagen-binding region
(DVI-III). Mutant and wild-type (WT) b3
chain cDNAs were retrovirally ex-
pressed in laminin b3 null junctional
epidermolysis bullosa (JEB Null) primary
keratinocytes (Waterman et al., 2007).
DVI, DVI-III, and WT keratinocytes
were cultured atop the devitalized
dermis as described (Ortiz-Urda et al.,
2003) and the resulting skin equivalents
were examined 3–4 weeks after grafting
to severe combined immunodeficiency
mice (Figure 1a). WT grafts showed no
clinical or microscopic blistering,
where as DVI and DVI-III grafts showed
significant subepidermal blistering and
erosions. Laminin-332 null grafts uni-
formly failed, with no evidence
of overlying human epidermis (not
shown).
Increased granulation tissue has long
been recognized as a characteristic
feature of patients with lethal and
non-lethal JEB (Marinkovich and Bauer,
2008). Interestingly, DVI and DVI-III
grafts also showed prominent granula-
tion tissue (Figure 1b), confirming an
association of granulation tissue with
laminin-332 defects. Non-blistered
areas of mutant grafts showed a linear
deposition of laminin-332 and type VII
collagen at the dermal–epidermal junc-
tion, similar to WT cells (Figure 1c),
suggesting that blistering/granulation
tissues in mutant skin equivalents wer-
enot due to reduced laminin-332 or
type VII collagen deposition at the
dermal–epidermal junction. As these
studies were performed in immunodefi-
cient mice, it is likely that laminin-332
defects promoted the development of
granulation tissue without the involve-
ment of the memory immune system.
Scanning and transmission electron
microscopic analysis (Figure 2a) of JEB
Null keratinocytes before grafting
showed marked rounding and poor
association with the culture surface,
compared with the flat and well-
attached WT keratinocytes. Both DVI
and DVI-III cells showed degrees of
flattening and culture substrate apposi-
tion intermediate between JEB Null and
WT cells.
Mutant DVI and DVI-III skin analy-
zed by transmission electron microscopy
4 weeks after grafting (Figure 2b)
showed rudimentary hemidesmosomes
(HDs) compared with WT grafts. An-
choring fibrils in DVI grafts were
hypoplastic compared with WT control,
whereas little or no anchoring fibrils
were seen in DVI-III skin equivalents.
Separation of both DVI and DVI-III
grafts occurred in the lamina lucida,
with a continuous lamina densa (LD,
arrows) on the dermal side of the split.
DVI-III skin grafts were noted to
contain both HD defects associatedAbbreviations: HD, hemidesmosome; JEB Null, null junctional epidermolysis bullosa; WT, wild type
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with lack of domain VI and type VII
collagen-binding defects associated
with lack of laminin b3 domain V-III.
However, despite these dual defects,
mutant grafts only showed lamina
lucida, as opposed to sub-lamina densa
separation. This suggests that the HD
defect in DVI-III grafts was more sig-
nificant and more easily disrupted by
external forces than the lack of type VII
collagen/laminin-332 binding asso-
ciated with the absence of laminin b3
domain V-III. As type VII collagen is
known to bind to other molecules,
including collagen IV in the lamina
densa (Burgeson et al., 1985) and
collagen I in the papillary dermis
(Villone et al., 2008), it is possible that
these interactions can partially stabilize
type VII collagen and provide a cohe-
sive force even in the absence of
laminin-332.
We previously noted that the DVI
mutant showed slightly decreased
laminin g2 chain processing (Waterman
et al., 2007); however, as inhibition of
g2 chain processing increases rather
than decreases adhesion (Gagnoux-
Palacios et al., 2001), g2 chain proces-
sing is not the likely reason for the
decreased DVI cell adhesion. The
laminin b3 short arm lies distant from
the integrin-binding a3 domain on the
laminin-332 molecule, and, as would
be expected, deletion of b3 domain VI
does not alter the binding of either
a3b1 or a6b4 integrins (Waterman
et al., 2007), ruling out integrin binding
as a possible cause of deficient DVI
adhesion.
In summary, this study introduces a
previously unreported animal model for
the study of the function of individual
domains of basement membrane zone
molecules in the process of dermal–
epidermal cohesion. This approach of
mutational structure–function analysis
has the potential to be used with other
WT ΔVI ΔVI-III
WT ΔVI ΔVI-III
WT
Type VII
collagen
Laminin-
332
ΔVI ΔVI-III
ΔVI
ΔVI-III
Figure 1. Clinical, histological, and immunofluorescent microscopic analysis of primary human xenografts expressing engineered laminin mutants. (a) Clinical
(upper panels) and microscopic (lower panels) appearance of human skin equivalents 3 weeks after xenografting to severe combined immunodeficiency
(SCID) mice. Grafts expressing wild-type (WT) and mutant (DVI, DVI–III) laminin-332 are shown as indicated (the arrows depict foci of granulation tissue in
mutant grafts). (b) Microscopic appearance of granulation tissue arising in mutant laminin xenografts. (c) Laminin-332 and type VII collagen expression in
xenografted skin as shown by immunofluorescent microscopy using the indicated antibodies. Bar¼ 100mm.
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null recessive epidermolysis bullosa
subtypes (for example, LAMC2,
LAMA3, COL7A1, COL17A1, ITGB4,
and ITGA6), which would further
extend our understanding of dermal–
epidermal cohesion.
We have also shown here that the
adhesion deficiencies associated with
deletion of laminin b3 domain IV are
associated with defects of HD forma-
tion. In vitro, normal keratinocytes
show central clustering of HD compo-
nents, distinct from peripheral focal
adhesions (Jones et al., 1998). HD
components in DVI cells, on the other
hand, localized to the cell periphery, in
close association with focal adhesions
(Waterman et al., 2007). In the current
in vivo study, HDs in DVI skin grafts
were poorly formed, compared with
control grafts. In addition, DVI skin
grafts separated at the intra-lamina
lucida level, exactly where a defect of
laminin-332/HD association would oc-
cur. Thus, in total, these findings
suggest that, through its promotion of
HD assembly, domain VI of the laminin
b3 chain has a significant role in
promoting dermal–epidermal cohesion
in the skin.
Also noteworthy is the inter-relation-
ship between granulation tissue forma-
tion and laminin-332 defects seen in
our studies. This confirms the clinical
observations made in JEB patients with
laminin-332 defects. Thus, future appli-
cations of this model may also help us
to understand better how epidermal
cells communicate with their associated
stromal and innate immune cells to
modulate wound healing.
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b3 null keratinocytes, retrovirally transduced with WT mutant DVI, mutant DVI-III, or vector control (Null) cDNA. Arrows in the lower panels point to areas of
poor apposition of keratinocyte plasma membrane with the culture surface. (b) Transmission electron microscopic analysis of the indicated intact (left three
panels) or separated (right two panels) graft areas. Arrows point to the lamina densa (LM). Abbreviations: AF, anchoring fibril; HD, hemidesmosome. Bar¼ 1 mm.
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